Deep Track Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
Deep Track Capital's ALNY Position: Q2 2026 in Review
Deep Track Capital opened a new position in Alnylam Pharmaceuticals (ALNY) in Q2 2026: 825,000 shares worth $248M. The stake represents 3.61% of the portfolio and ranks #5 among its holdings. This is a return to the name: Deep Track Capital previously reported a position in ALNY as recently as Q2 2024.
Deep Track Capital first reported a position in ALNY in Q1 2022 and has held it in 4 quarters since. 791 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.
- Deep Track Capital held 825,000 shares of Alnylam Pharmaceuticals worth $248M as of Q2 2026.
- Alnylam Pharmaceuticals was a new Deep Track Capital position in Q2 2026.
- Alnylam Pharmaceuticals made up 3.61% of Deep Track Capital's portfolio in Q2 2026, its #5 holding.
- Deep Track Capital first reported a position in Alnylam Pharmaceuticals in Q1 2022 and has held it in 4 quarters since.
- 791 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.
Based on Deep Track Capital's 13F filing for Q2 2026, filed 14 Aug 2026.